USNA

+ Watchlist + Portfolio

USANA Health Sciences, Inc.

Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $14.37
52-Week Range: $12.57 – $27.25
Market Cap: $273.82M
P/E (TTM): —
EPS (TTM): -1.20
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.52
PEG Ratio: 0.70
Return on Equity: -5.06%
Return on Assets: 3.61%
Gross Margin: 77.45%
Operating Margin: 4.09%
Profit Margin: -2.43%
Current Ratio: 2.66
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $49.13M
Revenue Growth: -5.30%
Earnings Growth: —
Enterprise Value: $149.93M

USNA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$998.60M	$921.01M	$854.50M	$925.26M
Cost of Revenue	$193.89M	$176.69M	$161.21M	$200.85M
Gross Profit	$804.71M	$744.32M	$693.29M	$724.40M
Selling, General & Admin	$262.30M	$256.99M	$263.27M	$337.37M
Operating Expenses	$697.10M	$651.25M	$626.97M	$673.54M
Operating Income	$107.61M	$93.07M	$66.32M	$50.86M
EBITDA	$130.22M	$123.11M	$98.86M	$82.07M
Pretax Income	$108.62M	$102.45M	$76.35M	$41.53M
Income Tax	$39.27M	$38.66M	$34.29M	$30.05M
Net Income	$69.35M	$63.79M	$42.03M	$10.76M
Diluted EPS	3.59	3.30	2.19	0.58
Diluted Shares	19.31M	19.34M	19.16M	18.57M

USNA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$288.42M	$330.42M	$181.77M	$158.38M
Receivables	$7.21M	$7.20M	$8.22M	$9.11M
Inventory	$67.09M	$61.45M	$69.73M	$102.61M
Current Assets	$384.38M	$417.75M	$279.19M	$288.40M
Total Assets	$596.55M	$632.76M	$748.19M	$742.91M
Current Liabilities	$143.83M	$118.84M	$139.63M	$128.56M
Total Debt	$6.89M	$8.06M	$29.01M	$19.65M
Total Liabilities	$162.08M	$135.56M	$161.86M	$156.64M
Retained Earnings	$391.64M	$445.22M	$478.94M	$465.72M
Shareholders' Equity	$434.47M	$497.20M	$532.11M	$533.10M
Working Capital	$240.55M	$298.90M	$139.56M	$159.84M

USNA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$103.90M	$70.64M	$60.99M	$22.35M
Capital Expenditure	-$10.40M	-$14.49M	-$10.07M	-$13.82M
Free Cash Flow	$93.50M	$56.15M	$50.92M	$8.53M
Depreciation & Amortisation	$21.41M	$20.39M	$22.23M	$39.70M
Stock-Based Compensation	$13.33M	$14.60M	$14.56M	$13.83M
Investing Cash Flow	-$12.37M	-$11.97M	-$213.09M	-$10.13M
Financing Cash Flow	-$30.09M	-$14.24M	$9.55M	-$40.60M
Share Repurchases	-$25.38M	-$11.60M	-$9.44M	-$27.51M
Net Change in Cash	$61.44M	$44.43M	-$142.54M	-$28.38M

USNA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$249.54M	$235.85M	$213.67M	$226.20M	$250.22M	$223.27M
Cost of Revenue	$52.45M	$50.18M	$48.81M	$49.41M	$59.44M	$48.34M
Gross Profit	$197.09M	$185.66M	$164.85M	$176.79M	$190.78M	$174.93M
Selling, General & Admin	$91.44M	$81.91M	$85.95M	$78.08M	$88.25M	$82.32M
Operating Expenses	$181.42M	$168.95M	$163.63M	$159.54M	$176.91M	$165.79M
Operating Income	$15.67M	$16.72M	$1.22M	$17.25M	$13.87M	$9.14M
EBITDA	$27.39M	$28.68M	$11.41M	$14.59M	$25.49M	-$9.73M
Pretax Income	$16.74M	$18.82M	$1.79M	$4.18M	$15.46M	-$18.90M
Income Tax	$7.45M	$8.37M	$8.46M	$5.77M	$8.51M	$9.05M
Net Income	$9.29M	$9.65M	-$6.52M	-$1.77M	$6.96M	-$21.38M
Diluted EPS	0.49	0.52	-0.36	-0.10	0.41	-1.16
Diluted Shares	19.09M	18.54M	18.29M	18.30M	18.41M	18.49M

USNA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$179.61M	$151.34M	$145.35M	$158.38M	$162.75M	$168.56M
Receivables	—	—	—	$9.11M	$9.66M	$3.34M
Inventory	$73.56M	$83.27M	$90.78M	$102.61M	$96.36M	$86.34M
Current Assets	$281.39M	$261.87M	$264.06M	$288.40M	$294.23M	$281.07M
Total Assets	$746.60M	$734.53M	$726.59M	$742.91M	$738.97M	$703.21M
Current Liabilities	$137.38M	$121.63M	$118.66M	$128.56M	$117.24M	$105.67M
Total Debt	$23.00M	—	—	$19.65M	$14.00M	—
Total Liabilities	$162.72M	$148.97M	$145.04M	$156.64M	$144.18M	$132.24M
Retained Earnings	$477.63M	$474.02M	$467.50M	$465.72M	$473.24M	$451.85M
Shareholders' Equity	$529.76M	$531.06M	$528.07M	$533.10M	$543.55M	$526.31M
Working Capital	$144.01M	$140.24M	$145.40M	$159.84M	$176.99M	$175.39M

USNA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$15.48M	$12.22M	-$1.96M	-$3.39M	$9.76M	$23.32M
Capital Expenditure	-$2.80M	-$5.03M	-$3.20M	-$2.79M	-$2.65M	-$3.15M
Free Cash Flow	$12.68M	$7.19M	-$5.16M	-$6.18M	$7.11M	$20.16M
Depreciation & Amortisation	$10.24M	$9.60M	$9.57M	$10.29M	$9.79M	$9.17M
Stock-Based Compensation	$2.88M	$3.62M	$3.58M	$3.75M	$3.45M	$3.40M
Investing Cash Flow	-$3.88M	-$4.16M	-$3.20M	$1.11M	-$2.60M	-$4.06M
Financing Cash Flow	-$14.47M	-$38.61M	-$979.00K	$13.45M	-$3.64M	-$14.03M
Share Repurchases	-$12.30M	-$15.21M	$0.00	$0.00	$0.00	$0.00
Net Change in Cash	-$2.86M	-$30.55M	-$6.14M	$11.17M	$3.52M	$5.24M

Market Snapshot

About

USANA Health Sciences is a global nutritional company that develops and manufactures high-quality nutritional supplements, weight management, and personal care products. The company sells its products through a network marketing distribution model in multiple countries around the world. USANA is known for its science-based approach to product development and its manufacturing facilities that follow strict quality standards.